<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from ICN
Pharmaceuticals, Inc.'s September 30, 1999 Consolidated Condensed Financial
Statements and is qualified in its entirety by reference to such financial
statements.
</LEGEND>
<MULTIPLIER> 1,000

                                                  
<PERIOD-TYPE>                   3-MOS                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1999             DEC-31-1999
<PERIOD-START>                             JUL-01-1999             JAN-01-1999
<PERIOD-END>                               SEP-30-1999             SEP-30-1999
<CASH>                                         180,264                 180,264
<SECURITIES>                                         0                       0
<RECEIVABLES>                                  240,838                 240,838
<ALLOWANCES>                                  (26,366)                (26,366)
<INVENTORY>                                    144,606                 144,606
<CURRENT-ASSETS>                               570,636                 570,636
<PP&E>                                         406,201                 406,201
<DEPRECIATION>                                (72,267)                (72,267)
<TOTAL-ASSETS>                               1,465,461               1,465,461
<CURRENT-LIABILITIES>                          150,907                 150,907
<BONDS>                                              0                       0
<PREFERRED-MANDATORY>                                0                       0
<PREFERRED>                                          1                       1
<COMMON>                                           783                     783
<OTHER-SE>                                     672,820                 672,820
<TOTAL-LIABILITY-AND-EQUITY>                 1,465,461               1,465,461
<SALES>                                        148,125                 459,209
<TOTAL-REVENUES>                               181,652                 534,887
<CGS>                                           54,133                 186,178
<TOTAL-COSTS>                                   54,133                 186,178
<OTHER-EXPENSES>                                 2,613                   7,875
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                              14,920                  41,794
<INCOME-PRETAX>                                 43,853                  97,597
<INCOME-TAX>                                    12,469                  24,369
<INCOME-CONTINUING>                             31,810                  80,274
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                    31,810                  80,274
<EPS-BASIC>                                      .41                    1.03
<EPS-DILUTED>                                      .39                     .98